EICHOR
● Recruiting
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Condition: Advanced Solid Tumors · Sponsor: Sun Pharma Advanced Research Company Limited
About this study
This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available in the country. The study involves multiple doses and takes place at several centers.
This description comes directly from the study's public registry record.
Talk to the study team
Dr. Sandeep Inamdar · 91-22-66455645 · clinical.trials@sparcmail.com
Always discuss trial participation with your own doctor first.
Locations (16)
| Honorhealth Research Institute | Scottsdale, Arizona, United States | Recruiting |
| Sarcoma Oncology Research Center | Santa Monica, California, United States | Recruiting |
| Yale University - Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Hope and Healing Clinical Research LLC | Hinsdale, Illinois, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Scientia Clinical Research | Randwick, New South Wales, Australia | Recruiting |
| Sunshine Coast University Private Hospital | Birtinya, Queensland, Australia | Recruiting |
| Cancer Research South Australia | Adelaide, South Australia, Australia | Recruiting |
| Kainos Super Speciality Hopsital | Rohtak, Haryana, India | Not Yet Recruiting |
| Amrita Institute of Medical Sciences | Ernākulam, Kerala, India | Not Yet Recruiting |
| Sir H.N Reliance Foundation Hospital | Mumbai, Maharashtra, India | Not Yet Recruiting |
| Tata Memorial hospital | Mumbai, Maharashtra, India | Recruiting |
+ 4 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07042100